Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Inotiv Inc.

Start price
Target price
Perf. (%)
€3.96
01.04.23
€2.00
01.04.24
10.10%
15.04.23

Probably not worthwhile Investment
Below average Management
Bad culture
buy
Cidara Therapeutics Inc

Start price
Target price
Perf. (%)
€1.08
25.01.23
-
25.01.24
-9.02%
14.04.23

Risky Investment
buy
Gensight Biologics SA

Start price
Target price
Perf. (%)
€2.34
07.04.22
-
07.04.23
-1.02%
08.04.23

Could be worthwhile Investment >10% per year
buy
Cellectis SA ADR

Start price
Target price
Perf. (%)
€4.20
03.04.22
-
03.04.23
-58.10%
04.04.23

Could be worthwhile Investment >10% per year
Vyant Bio Inc.

Start price
Target price
Perf. (%)
€1.55
05.01.23
-
05.01.24
-65.81%
02.04.23

PAVmed Inc

Start price
Target price
Perf. (%)
€1.41
20.03.22
-
20.03.23
-80.13%
21.03.23

Probably not worthwhile Investment
Gensight Biologics SA

Start price
Target price
Perf. (%)
€2.97
07.03.22
-
07.03.23
-19.53%
08.03.23

Risky Investment
buy
iBio Inc.

Start price
Target price
Perf. (%)
€1.34
02.03.23
€2.60
02.03.24
15.45%
06.03.23

Could be very worthwhile Investment >20% year
buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€7.59
01.04.22
€12.50
01.04.23
-76.56%
04.03.23

Could be worthwhile Investment >10% per year
iBio Inc.

Start price
Target price
Perf. (%)
€1.21
26.02.23
€0.000
26.02.24
27.85%
04.03.23

Some uniques
Significant cyclical dependencies
Little known brand
Higher risks for its business
iBio Inc.

Start price
Target price
Perf. (%)
€1.50
13.10.22
€0.10
13.10.23
-21.39%
27.02.23

Capable Management
Good culture
Valuable balance sheet
Dependend from some customers or products
Cidara Therapeutics Inc

Start price
Target price
Perf. (%)
€1.58
07.02.23
€1.00
07.02.24
-5.06%
18.02.23

Probably not worthwhile Investment
Below average Management
Bad culture
buy
Cidara Therapeutics Inc

Start price
Target price
Perf. (%)
€0.78
21.09.22
€3.00
30.04.23
87.12%
06.02.23

Could be very worthwhile Investment >20% year
buy
Sernova Corp.

Start price
Target price
Perf. (%)
€0.65
05.01.23
€25.00
05.02.23
23.66%
06.02.23

Could be very worthwhile Investment >20% year
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€6.05
22.01.23
-
22.01.24
3.80%
05.02.23

Could be very worthwhile Investment >20% year
buy
Theranexus

Start price
Target price
Perf. (%)
€3.18
04.02.22
€36.00
04.02.23
-41.98%
05.02.23

Could be worthwhile Investment >10% per year
buy
Visiomed Group

Start price
Target price
Perf. (%)
€0.17
24.01.22
-
24.01.23
116.40%
25.01.23

Could be worthwhile Investment >10% per year
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€4.62
16.11.22
€1.00
16.11.23
26.73%
23.01.23

Little Investments for future growth
No Innovation
Significant cyclical dependencies
Very bad culture
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€5.52
13.01.23
-
13.01.24
9.62%
21.01.23

Risky Investment
buy
Purple Biotech Ltd. ADR

Start price
Target price
Perf. (%)
€3.52
21.01.21
€60.00
21.01.23
-54.26%
21.01.23

Could be very worthwhile Investment >20% year
buy
Evoke Pharma Inc.

Start price
Target price
Perf. (%)
€28.25
21.01.21
€120.00
21.01.23
-86.83%
21.01.23

Could be very worthwhile Investment >20% year
buy
Nanorepro AG

Start price
Target price
Perf. (%)
€6.38
10.01.22
€7.50
10.01.23
-64.19%
10.01.23

Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Higher risks for its business
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€3.98
12.12.22
-
12.12.23
1.61%
09.01.23

Could be worthwhile Investment >10% per year
Very high cyclical dependencies
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€1.24
17.11.22
-
17.11.23
0.48%
26.12.22

Risky Investment
buy
Euromedis Groupe

Start price
Target price
Perf. (%)
€10.64
24.12.21
-
24.12.22
-57.99%
25.12.22

Could be worthwhile Investment >10% per year